SMART PRONIOSOMAL TRANSDERMAL PLATFORMS FOR CONTROLLED LOCAL ANESTHETIC DELIVERY OF LIDOCAINE

Aditya Kumar*, Vivek Gupta, Jitendra Kumar Malik, Gyan Singh

Localized pain control increasingly demands delivery systems that behave intelligently at the skin interface, delivering anesthetic precisely where needed while avoiding systemic spillover. Lidocaine, despite its clinical versatility, remains constrained by short duration of action and frequent reapplication when administered through conventional routes. Transdermal delivery offers an attractive alternative, yet the skin barrier and uncontrolled diffusion continue to limit therapeutic performance. Smart proniosomal transdermal platforms introduce a disruptive shift by coupling vesicular nanotechnology with skin-triggered self-assembly and controlled release behavior. Proniosomes are dry, storage-stable precursors that transform into niosomal vesicles upon hydration on the skin surface, generating a localized drug depot within the stratum corneum and viable epidermis. This review presents an integrative and forward-looking analysis of lidocaine-loaded proniosomal systems, focusing on formulation-driven control over vesicle architecture, interfacial dynamics, and anesthetic release profiles. The influence of surfactant chemistry, cholesterol content, and penetration enhancers on vesicle stability, drug entrapment, and dermal retention is critically examined. Advanced in vitro, ex vivo, and in vivo evaluation strategies are discussed to highlight prolonged anesthetic action, enhanced skin residency, and reduced systemic exposure. Beyond sustained delivery, proniosomal platforms enable modulation of spatial and temporal drug distribution, positioning them as precision-oriented systems rather than passive carriers. Emerging directions, including stimuli-responsive proniosomes, biointeractive excipients, and patient-adaptable designs, are highlighted as enablers of next-generation local anesthesia. Collectively, smart proniosomal transdermal systems redefine lidocaine delivery, offering a clinically compelling, scalable, and future-ready pathway for localized pain management in modern anesthetic and dermatological practice settings.